Tuesday
07.16.2019
4:57 AM
Login form
Search
Calendar
Entries archive

My site

Main » 2018 » October » 29

The complaints filed by Immervision accuse LG models LG G6, LG V20, LG V30, LG G7 and LG V35 of infringing Immervision’s U.S. Patent No. 6,844,990

MONTREAL-Thursday 25 October 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Immervision, a Montreal-based developer of patented, wide-angle optic and imaging technology, filed patent infringement lawsuits against LG Electronics and LG Electronics U.S.A., Inc. in the Unites States District Court for the District of Delaware. The patent is generally related to wide-angle imaging technology in the areas of lens design and software-based image processing.

Immervision holds multiple patent families in imaging technology and has successfully enforced its patents in the past.

Pascale Nini, Immervision President and CEO, said “As the experts in wide-angle imaging technology, our purpose is to enable intelligent vision for any industry and application, and make Immervision intellectual property available to all ... Read more »

Views: 28 | Added by: africa-live | Date: 10.29.2018 | Comments (0)

SAN FRANCISCO -Wednesday 24 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Visa (NYSE: V) today announced a continued commitment to reducing friction and improving security in digital commerce by reiterating support of the draft EMV® Secure Remote Commerce (SRC) Specification.

The draft EMV SRC Specification provides a foundation for digital transactions that gives consumers, merchants and issuers a single digital point-of-sale, resulting in a consistent, convenient and secure way to pay. EMVCo has spent the last year gathering feedback from across the payment ecosystem on the specification. Visa now encourages merchants, issuers, acquirer gateways and other interested participants to provide feedback and comment during a 45-day public comment window. Once complete, EMVCo will publish the final specification.

Shoppers are increasingly migrating to websites, mobile phones and voice-activated devices, but their buying experiences are full of friction because ... Read more »

Views: 27 | Added by: africanewsline | Date: 10.29.2018

Dr. Richard Goulding to Assume Leadership Role as Chief Medical Officer, Focused on Diamond CBD Product Development and Clinical Trials

FORT LAUDERDALE, Fla.-Friday 26 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- PotNetwork Holdings, Inc. (OTC Pink: POTN) (the “Company”) announced today that Kevin Hagen, President of its subsidiary, First Capital Venture Co., owner of Diamond CBD, Inc., has been appointed as new Chief Executive Officer effective immediately.

Former CEO, Dr. Richard Goulding, assumes the new role of Chief Medical Officer, spearheading new product development and clinical testing of new proprietary products. Dr. Goulding will devote his time solely to this role, terminating any involvement with other entrepreneurial initiatives and affiliations, private or public, in the CBD industry. Dr. Goulding will focus on product development, in an effort to expand and enhance the Company’s offerings.

Kevin Hagen, new CEO, state ... Read more »

Views: 33 | Added by: africa-live | Date: 10.29.2018 | Comments (0)

Abu Dhabi, United Arab Emirates-Wednesday 24 October 2018 [ AETOS Wire ]

Nashwa Al Ruwaini, the Emirati entrepreneur was one of the winners of the Mother Teresa Memorial Award for Social Justice 2018. She was awarded for all her philanthropic efforts in revolutionizing the image of women in the Middle East as well as all her charitable activities that she has undertaken to improve the lives of women and children through her humanitarian organization-the Nashwa Foundation.

Al Ruwaini was granted the award in Mumbai India at a ceremony organized by the Harmony Foundation following a conference with the theme of ‘Protect Her Empower Her’ focused on the empowerment of the girl child where Al Ruwaini spoke about the role of lobbying for laws, society and technology in protecting and empowering young women-a cause Al Ruwaini is very dedicated to. She received the award from the great grandson of the legendary Mahatma Gandhi, Mr. Shri Tushar Arun Gandi in the pr ... Read more »

Views: 29 | Added by: africa-live | Date: 10.29.2018 | Comments (0)

GOTHENBURG, Sweden -Wednesday 24 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Mentice, the world leading provider of endovascular performance solutions, announced today the appointment of a new independent member to its Board of Directors.

David J. Ballard, M.D., M.S.P.H., Ph.D., F.A.C.P., is a global healthcare executive with proven expertise in improving healthcare value and organizational financial performance while providing international thought leadership. Dr. Ballard was recognized by Becker’s as one of the top 50 experts leading the field of Patient Safety in 2015, 2016, 2017 and 2018 and is the past President of the International Society for Quality in Healthcare. Widely recognized as a global scholar in healthcare quality and value, his two books on healthcare quality leadership received Shingo Awards for their contributions to operational excellence.

“I am excited to join the Mentice board of directors,” says David Ballard, &ldqu ... Read more »

Views: 27 | Added by: africa-live | Date: 10.29.2018 | Comments (0)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 


OSAKA, Japan-Sunday 28 October 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today issued the following statement with regard to its discussions with the European Commission (“EC”) as part of its Phase 1 review of the proposed acquisition of Shire plc (“Shire”) announced on May 8, 2018 (the “Acquisition”):

Takeda confirms that it is in discussions with the EC in relation to the future potential overlap in the area of inflammatory bowel disease between Takeda’s marketed product Entyvio (vedolizumab) and Shire’s pipeline compound SHP647, which is currently in Phase III clinical trials, and has proposed a remedy of a potential divestme ... Read more »

Views: 30 | Added by: africanewsline | Date: 10.29.2018

Dubai, United Arab Emirates-Sunday 28 October 2018 [ AETOS Wire ]

HE Mattar Al Tayer, Director-General and Chairman of the Board of Executive Directors of Dubai Roads and Transport Authority (RTA), announced that the participation in the Dubai World Challenge for Self-Driving Transport had exceeded the target by 30%, by the end of registration phase. Al Tayer made this statement during a press conference held to announce the finalists of the Challenge.

Companies, universities, colleges and institutions submitted applications globally. Attendees of the event included Dr. Arif Al Hammadi Executive Vice President of Khalifa University, Ms. Laila Faridoon, Chairperson of the Organising Committee of the Dubai World Congress for Self-Driving Transport; Dr. Steve Shladover, the International Jury Head of Dubai World Challenge for Self-Driving Transport; and Adel Shakri, Head of the Dubai World Challenge for Sel ... Read more »

Views: 50 | Added by: africa-live | Date: 10.29.2018 | Comments (0)

CAMBRIDGE, Mass. & OSAKA, Japan-Sunday 28 October 2018 [ AETOS Wire ]

– Six Abstracts to be Presented to Highlight the Potential Impact of ADCETRIS® (brentuximab vedotin) for the Treatment of Hodgkin Lymphoma –

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature a total of six company-sponsored abstracts, including two oral presentations, at the 11th International Symposium on Hodgkin Lymphoma (ISHL), October 27-29, 2018, in Cologne, Germany. This year’s presentations will highlight Phase 3 and other clinical data from ADCETRIS (brentuximab vedotin) and continue to build upon our research in CD30-positive lymphoma.

“Data to be presented at this year’s ISHL continue to reinforce Takeda’s dedication to advancing treatment for those affected by Hodgkin lymphoma,” said Jesús Gómez-Navarro, M.D., Vice President, Head of Oncology Clinical Research and De ... Read more »

Views: 28 | Added by: africa-live | Date: 10.29.2018